Cushing's Syndrome

Endocrinology·MeSH: Cushing Syndrome

3 drugs in development·3 companies·0 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
korlym	CORCEPT THERAPEUTICS INC (CORT)
Recorlev	Xeris Biopharma Holdings, Inc. (XERS)

Phase 3(1)

Drug	Company
recorlev	Strongbridge Biopharma plc (SBBP)

Full trial data, competitive analysis, and AI-powered pipeline tracking.